Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases



Comments are closed.

Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform
Leading Consumer 3D Printing Company, New Matter, Raises $6.5M in Series A Funding
Dolby Family Launches Institutional Venture Fund
DigiLens Secures Investment from UDC Ventures and Samsung Ventures for Holographic AR Displays